iBio, Inc. Reports Fiscal 2026 Year‑End Financial Results

What Happened

• iBio, Inc. announced its financial results for the fiscal year ended June 30, 2026 in a press release dated August 28, 2026. The company furnished that press release as Exhibit 99.1 to its Form 8‑K filed the same day.

Key Details

• Filing date: August 28, 2026 (Form 8‑K, Item 2.02).
• Reporting period: fiscal year ended June 30, 2026.
• The press release announcing the results is furnished as Exhibit 99.1 to the Form 8‑K.
• The report was signed on behalf of iBio by Marc A. Banjak, Chief Legal Officer.

Why It Matters

• This 8‑K notifies investors that iBio has publicly disclosed its year‑end financial results; the press release will contain the company’s reported revenue, earnings (or loss), cash position and other key metrics investors use to assess performance.
• Investors should read the furnished press release (Exhibit 99.1) and any related SEC filings for full financial details and context before making investment decisions.